Delivery Order SPE2DR25D7068-SPE2DR26F5BW0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,372.05 to AmerisourceBergen Drug Corp for Act-O-Vials on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed price, non-set-aside contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order represents a routine pharmaceutical supply transaction within the federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $11,348.20 to AmerisourceBergen Drug Corp on December 4, 2025, for Act-O-Vials medical supplies. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to complete by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,656.20 to AmerisourceBergen Drug Corp for Act-O-Vials on December 8, 2025, with completion expected by December 9, 2025. This is a firm fixed price, non-set-aside contract supporting pharmaceutical distribution to federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive portfolio of...
- The Defense Logistics Agency awarded a $20,986.24 delivery order contract to AmerisourceBergen Drug Corp for Act-O-Vials on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $13,585.12 delivery order (4570221803) to AmerisourceBergen Drug Corp for Act-O-Vials, a pharmaceutical product delivery, with performance in Conshohocken, Pennsylvania and completion by December 10, 2025. This is a firm fixed-price, non-set-aside contract executed on December 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $7,940.76 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 4, 2025, with completion expected by December 5, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a small transactional order within AmerisourceBergen's broader federal pharmaceutical supply portfolio....
- The Defense Logistics Agency awarded a delivery order valued at $10,604.05 to AmerisourceBergen Drug Corp on December 11, 2025, for ACT-O-VIALS pharmaceutical products. The contract represents a firm fixed price delivery order with an ultimate completion date of December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded through open competition. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,519.80 to AmerisourceBergen Drug Corp for Act-O-Vials on November 20, 2025, with completion scheduled for November 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing support to federal medical procurement, leveraging the...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BW0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,641.60 to AmerisourceBergen Drug Corp on December 8, 2025, for Act-O-Vials, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The contract supports various federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 12/7/25 |